CVSGF(CVSGF)
CVSGF
No analyst ratings available
No analyst price targets available for CVSGF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|
| Revenue Avg | $1.01B | $1.05B | $1.09B | $1.12B |
| Low | $987M | $1.03B | $1.07B | $1.10B |
| High | $1.02B | $1.06B | $1.10B | $1.13B |
| EBITDA Avg | $237M | $247M | $262M | $264M |
| Low | $233M | $242M | $258M | $260M |
| High | $238M | $249M | $265M | $266M |
| EBIT Avg | $161M | $176M | $194M | $198M |
| Low | $158M | $172M | $190M | $193M |
| High | $163M | $178M | $197M | $200M |
| Net Income Avg | $92M | $101M | $113M | $116M |
| Low | $90M | $99M | $110M | $113M |
| High | $94M | $103M | $115M | $117M |
| EPS Avg | $1.29 | $1.41 | $1.58 | $1.61 |
| Low | $1.26 | $1.38 | $1.54 | $1.57 |
| High | $1.31 | $1.43 | $1.60 | $1.63 |
| Analysts (Rev / EPS) | 9 / 1 | 3 / 1 | 4 / 1 | 4 / 1 |